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1INTRODUCTION
Obesity is a major public health problem in developed countries and
an emerging health problem in developing nations, such as India. According
to WHO report in 2016, 650 million adults were obese1. India ranks 3 in the
top 10 countries with obese people with a count of 40.4 million2. Obesity is
well-recognized as a main risk factor for the development of metabolic
disorders and cardiovascular disease (CVD), such as heart failure,
myocardial infarction, and stroke. Obesity is also said to be one of the most
ignored health problems3
Obesity isdefined as a state of excessive accumulation of adipose
tissue mass4. It can be said as weight exceeding 10% of standard weight.
Obesity is also a disease of caloric imbalance that results from an excess
intake of calories that exceeds their consumption by the body. Excess energy
is stored in the Adipose tissue as triglycerides and release the stored energy
in the form of free fatty acids when the need arises for use at various
sites5.Hormones like Leptin play a key role by binding to receptors in the
hypothalamus and increasing energy consumption.
Excess weight gain is best assessed by the body mass index, or
BMI due to its suitability and non-invasiveness .The normal BMI range is
18.5 to 23.5 kg/m2 in Asian Indian population. Central, or visceral obesity
2is associated with a much higher risk for several diseases than is
subcutaneous fat.
Obesity, a part of the systemic inﬂammation, originates from
Adipose tissue (AT), where inﬂammatory cells, mainly macrophages and T-
lymphocytes accumulate creating local inﬂammation (6,7,8). Adipose
tissue-derived inﬂammatory factors impinge on vascular cells to promote
the development of atherosclerosis in obese people. This systemic
pathologic process occurring in the vascular system is atherosclerosis.
Atherosclerosis in arterial wall is initiated by fat retention, oxidation,
and modification resulting in intima-media thickening (IMT). This provokes
chronic inflammation, which underlies the pathogenesis of coronary,
cerebral and peripheral vascular disease. Various risk factors act in concert
and cause vessel intimal lesions called atheromas (atheromatous or
atherosclerotic plaques) that protrude into vessel lumens. Besides
mechanically obstructing blood flow, plaques can also rupture leading to
catastrophic thrombosis.9
Hypertension is also a risk factor for development of atherosclerosis,
a systemic condition primarily affecting elastic arteries (carotid, aorta, and
iliac arteries) as well as large and medium-sized muscular arteries. Arterial
wall modifications represent an early involvement of the target organs in
patients with hypertension[10,11].
3Ultrasound measurements of IMT and plaque occurrence in the
carotid arteries are important as the extent of arteriosclerosis and
atherosclerosis in these vessels reflects the severity of arterial damage in
other vascular territories[12,13].
High resolution ultrasonography is a non invasive, simple, safe
(non ionising) inexpensive, precise, and reproducible method of examining
and evaluating the walls of carotid arteries. Extra cranial carotid arteries are
chosen for IMT assessment because of their superficial location, easy
accessibility, adequate size, and limited movement[14]. Even though obesity
prevalence is increasing at an alarming rate in India, few Indian studies are
available to study the atherosclerotic changes occurring in the vascular
system with the body mass index and blood pressure in a simple, universal
and non invasive manner. Hence this study is undertaken to throw    light on
this aspect.
4AIM
The aim of this study is
1) To correlate BMI with the  carotid IMT values in adults
2)To correlate Blood pressure measurements with the carotid IMT
values in  adults
5MATERIALS AND METHODS
STUDY DESIGN: Cross-sectional type of study.
STUDY CENTRE AND PERIOD: Tirunelveli Medical College Hospital
Period -October 2017 to August 2018
SAMPLE SIZE: 100 subjects
ETHICAL CONSIDERATIONS:
Institutional ethical committee clearance was obtained prior to the
commencement of the study. The patients who were attending the non-
communicable disease OPD were recruited for this study. All the subjects
were clearly explained about the study in their own language. Informed
consent was obtained from those who were willing to participate in this
study.
INCLUSION CRITERIA:
 Patients of  both the sex
 Age group of 30-60 years
 Hypertensive cases
EXCLUSION CRITERIA:
 Known diabetic patients
 Known Ischemic heart disease
6 Known cerebro vascular accidents
 Bronchial Asthma
 Vasculitis disorders
 Thyroid  and other  Endocrine disorders
 History of Chronic steroid therapy
 Body builders
 Pregnancy
METHODOLOGY:
After getting informed consent, the information about personal details, brief
medical history was noted in a separate proforma sheet.
Height and weight measurements were taken following a standard protocol.
WHO STEPS Surveillance- Training & Practical Guides-Guide to
Physical Measurements
Measurement of Height:
1.Ask the participant to remove their:
• Footwear (shoes, slippers, sandals etc)
• Head gear (hat, cap, hair bows, comb, ribbons, etc).
2.Ask the participant to stand on the board facing you
73 Ask the participant to stand with:
• Feet together  • Heels against the back board • Knees straight
4 Ask the participant to look straight ahead and not look up.
5 Make sure eyes are the same level as the ears.
6 Move the measure arm gently down onto the head of the participant and
ask the participant to breathe in and stand tall.
7 Read the height in centimetres at the exact point.
8 Ask the participant to step away from the measuring board
Measurement of weight:
1.Ask the participant to remove their footwear (shoes, slippers, sandals etc)
and socks.
2. Ask the participant to step onto scale with one foot on each side of the
scale.
3. Ask the participant to:
• stand still • face forward • place arms on the side and  • wait
until asked to step off
4.Record the weight in kilograms on the participant’s Instrument
8Measurement of BMI:
BMI was calculated using Quetlet’s formula: weight (kg)/ height (m2).
BMI(kg/m2) Classification
18.5-22.9 Normal
23.0-24.9 Overweight
>25 Obese
Measurement of Blood pressure of a participant using the
sphygmomanometer.
Ask the participant to sit quietly and rest for 15 minutes with their legs
uncrossed.
1.Place the right arm* of the participant on the table with the palm facing
upward.
2. Remove or roll up clothing on the arm.
3. Select the appropriate cuff size for the participant using the following
table:
9Arm Circumference (cms) Cuff Size
22-32 Medium (M)
> 32 Large (L)
4. Position the cuff above the elbow aligning the mark ART on the cuff
with the brachial artery.
5. Wrap the cuff snugly onto the arm and securely fasten with the Velcro.
Note:  The lower edge of the cuff should be placed 1.2 to 2.5 cm above the
inner side of the elbow joint.
6. Keep the level of the cuff at the same level as the heart during
measurement
7. Put stethoscope earpieces in ear and set to bell.
8.Palpate pulse at either brachial or radial artery.  Take a pulse count for
one full minute.
9. Pump up pressure and inflate cuff until unable to feel pulse.
10. Continue to inflate cuff 30 mmHg beyond this point.
11. Apply the bell of the stethoscope to the right antecubital fossa.
12.Listen for pulse sounds while deflating the cuff slowly.
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13.Record the systolic blood pressure (SBP) when a pulse is first audible.
14. Record the diastolic blood pressure (DBP) when the pulse sound
disappears.
15. Deflate the cuff fully and let the arm rest for three minutes (between
each of the readings).
16. Repeat Steps 2-7 twice to obtain three readings (and take the mean of
the second and third readings for analysis purposes).
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Measurement of carotid artery intima media thickness (CIMT)
Examination of carotid artery was performed in Radiology
department with a high-resolution ultrasound doppler scanner
SCONOSCAPE, equipped with a 7 MHz linear array transducer. The patient
being in supine position and chest being elevated with a pillow and the head
being turned to the opposite side of the carotids to be examined. The probe
will be placed on the medial side of the sternocleidomastoid muscle to
identify the carotid vessel and the carotid bulb will be traced. The carotid
wall will show parallel echogenic lines separated by a hypoechoic region
(media). The inner line is the lumen – intima interface and the outer is the
media – adventitia interface.
12
Carotid IMT was measured on both sides and the average value is
taken as the mean CIMT. Multiple projections were used to acquire images
of the left and right common carotid, bulb and internal carotid arteries.
Measurements were taken in the carotid bulb and 1cm proximal and distal
to the bulb including CCA and ICA respectivelly. The average of three
measurements of each carotid artery will be taken as mean thickness (CIMT)
13
The intimal plus medial thickness (IMT) was measured as the distance
from the leading edge of the first echogenic line to the second echogenic
line. The first echogenic line represents the lumen intimal interface and the
second line is produced by media-adventitia interface.
IMT values above 0.9mm are regarded as abnormal. Focal thickening
of the luminal surface >1.5 mm is called as plaque.
14
REVIEW OF LITERATURE
BODY MASS AND OBESITY
Definition of Obesity
Obesity is broadly defined as a state of excess adipose tissue mass.
Growing evidence suggests that obesity is a disorder of the energy
homeostasis system, rather than simply arising from the passive
accumulation of excess weight.Reliable fat-mass quantitation requires
sophisticated tools that are not widely available (e.g., magnetic resonance
imaging or dual energy X-ray absorptiometry)15.
PREVALENCE OF OBESITY
GLOBAL SCENARIO
According to WHO report in 2016, 650 million adults were
obese.39% of adults aged 18 years and over (39% of men and 40% of
women) were overweight. Overall, about 13% of the world’s adult
population (11% of men and 15% of women) were obese in 2016. Over 340
million children and adolescents aged 5-19 years were overweight or obese
in 2016.Obesity is now on the rise in low- and middle-income countries,
particularly in urban settings. Overweight is linked to more deaths
worldwide than underweight16.
15
INDIAN SCENARIO
There were 20 million obese women and 9.8 million obese men in India
in 2014 according a study published in the British medical journal, Lancet.
Severe obesity was observed in an additional 4 million Indian women. The
study, comparing body-mass index from 1975 to 2014 from adults in 186
countries showed a more significant rise in obesity in India from its 19th
position for both men and women in 1975 to rankings 5th and 3rd respectively
in 2014(17).
OBESITY AND ANTHROPOMETRY
Anthro pometry literally   means  “Human Measure”.
Anthropometry is the study of measurement of human body in terms
of dimensions of bone, adipose tissue and muscle.  It is a key component of
nutrition status assessment both in children and adults(18).
Overweight and obesity classification are done by Body Mass Index
(BMI).
Body Mass Index(BMI):
It is the value obtained by dividing the actual body weight in
kilograms by the height of the body in square meters. It acts as a surrogate
measure of body fatness and is the most widely accepted deﬁnition of
obesity. BMI satisﬁes our need to estimate body-fat mass at a population
level and thus gauge a group’s susceptibility to complications of obesity.
16
BMI is not used for body builders, pregnant women, elderly, long distance
athletes and young children.
WHO GUIDE LINES-OVER WEIGHT AND OBESITY-
 WHO Expert consultation concluded that Asian populations have a
higher risk even at lower BMI. The cut-off point for observed risk
varies from 22 to 25kg/m2 and for higher risk starts from 26 to 31
kg/m2. BMI greater than 23kg/m2 are said to be overweight and
greater than 25kg/m2 are said to be obese for Asian Indians19.
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The BMI for native Asian Indians 24
Classification Obesity Class BMI(kg/m2)
Under weight <18.5
Normal 18.5-22.9
Overweight 23.0-27.9
Obesity I 28.0-32.9
II 33.0-37.9
Extreme obesity III ≥38
WHO GUIDELINES
Percent ideal body weight:
 Overweight: 10 to 20% above the reasonable body weight
 Obese: more than 20% above the reasonable body weight
The obese persons can be classified further as
 Mildly obese: 20-40% overweight
 Moderately obese: 41 to 100% overweight
 Severe (extremely): greater than 100% overweight
As the BMI value is same for all ages and sexes of adults, it gives
more information about the population level measure of obese and also
overweight25,26,27. BMI was considered a superior tool in correlating the
effect of weight with morbidity and mortality. At the same BMI values,
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Asians of Indian origin tend to have 7-8% of higher percentage body fat than
Europoids28with increased prevalence of cardiovascular risk and  diabetes.
Weight gain of about 5 kg during 18-20 years of life, increases the risk of
developing hypertension, diabetes and CHD.29
VARIOUS PATTERNS OF OBESITY
Central obesity or android obesity or upper body obesity is the type
of obesity which is most likely to be associated with an altered risk factor
profile contributing to an increased CVD and type 2 diabetes risk.
Gynoid obesity or, lower body obesity with fat located around the hips
and buttocks) is seldom associated with such metabolic complications
“Normal Weight Obesity” is defined as a condition of having normal
BMI but the percentage of body fat is high30.
TOFI (Thin on the outside, fat on the Inside) are those people with
BMI within normal limits with high intra-abdominal fat and thus more
susceptible to DM. Fat fit phenotype have greater BMI but metabolically
normal31.
Thus obesity consequences are linked to the amount of intra
abdominal fat rather than fat at other areas like buttocks and hip32.This
central abdominal obesity is associated with increased incidence of
hypertension and atherogenic lipid profile both of which can increase the
chance of cardiovascular disease33,34.
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ENERGY BALANCE:
The major fundamental cause of obesity and overweight is an
imbalance between calories consumed and calories expended.
Gastrointestinal tract has the capacity to absorb large quantity of nutrients.
In 1 year, only 5% increase in caloric intake than energy expenditure will
lead on to 5kg increase in weight in adipose tissue. Total daily energy
expenditure (TEE) includes resting energy expenditure (REE) (70%),
thermic effect of food (10%) and energy expended during physical activity
(20%). REE denotes the energy expended for normal organ and cellular
function during post absorptive resting state35. Thermic effect of food (TEF)
denotes the energy expended after ingestion of a meal. Obese persons
usually have higher REE than lean persons of same height.
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DIETARY LIPIDS / LIPO PROTEINS
The major constituents of dietary lipids are chiefly long chain
triglycerides with lesser amounts of phospholipids, cholesterol, cholesterol
esters and fat soluble vitamins36. The major route of normal intestinal
absorption of lipids is through lymphatics. Many types of lipoprotein are
exist each having characteristic lipid and protein compositions. The various
classes are 1) Chylomicrons 2) VLDL 3) LDL 4) HDL
1. Chylomicrons transport lipids absorbed from the intestine to adipose,
cardiac, and skeletal muscle tissue, where their triglyceride components
are hydrolyzed by the activity of the lipoprotein lipase, allowing the
released free fatty acids to be absorbed by the tissues.
2. VLDL and LDL transfer triacylglycerols (TAG) and cholesterol from
liver to other tissues by endogenous lipid transport.
3. HDL transport cholesterol from extra hepatic tissues to liver by reverse
cholesterol transport.
Another subclass, Lipoprotein(a) [Lp(a)] consists of an LDL-like
particle and the specific apolipoprotein(a) [apo(a)], which is bound
covalently to the apoB of the LDL-like particle and its plasma
concentrationare highly heritable and mainly controlled by the
apolipoprotein(a) gene  located on chromosome 6q37.
21
STORAGE OF LIPIDS AS TRIGLYCERIDES
Triglycerides are stored in the adipose tissue as body's major energy
reserve. Triglycerides are a much more compact fuel than glycogen, yielding
9.3kcal/g upon oxidation.Most of the triglyceride are derived from
chylomicrons and very-low-density lipoprotein (VLDL) triglycerides that
originate,respectively, from dietary and hepatic sources40.
ROLE OF HORMONES:
22
Body weight regulation is coordinated by hormones and neuronal
circuit. A major hormone regulating these adaptations is LEPTIN, an
adipocyte derived hormone which circulates at concentrations proportional
to body-fat mass, plays a signiﬁcant role in the relationship between obesity
and energy homeostasis. Other major hormonal signals are insulin, gut
peptides and cortisol. Hormones like Neuropeptide YY (NPY), Agouti
related peptide (AgRP), Melanocyte concentrating hormone(MCH), cortisol
and Ghrelin stimulate appetite. Melanocyte stimulating hormone MSH and
Leptin, decrease appetite. Peptide tyrosine(PYY3-36) is produced in the gut
cells and their production is proportional to the kcal intake. This hormone is
particularly produced after a meal and signals the brain, that the body is no
longer hungry.
23
FAT AS AN  ORGAN
Adipose tissue is collection of connective tissue in which
adipocytes or fat cells are predominating and constitutes 15-20% of the
body weight in men while in women a little higher41. Adipose tissue as
an endocrine tissue respond to both neural and hormonal stimuli.
Adipose tissue helps in thermal insulation, cushioning and keeping the
organs in its place. 85% of total adipose tissue mass is found under the
skin called subcutaneous fat. Very smaller amount is seen within the
abdomen called intra-abdominal fat or visceral fat. This includes both
retroperitoneal fat (drains into systemic circulation) and intraperitoneal
24
fat (drains into portal circulation). Mesenteric and omental fat comes
under intraperitoneal category42.
Excess energy stored in subcutaneous tissue will overflow to
IAAT and skeletal muscle and liver producing metabolic dysfunction.
Metabolic products of omental and mesenteric fat tissue are released into
portal vein PI in abdominal areas.
The size of the adipocytes can increase up to 10 times called as hypertrophy.
When the upper limit of fat storage is reached by hypertrophy then the fat
cells now undergo hyperplasia. New adipocytes are developed from
immature precursor cells. Once created, the number of fat cells cannot be
25
reduced naturally. This is the reason why obese persons have a greater
difficulty in losing weight once it has been achieved43
PATHOGENESIS OF OBESITY
GENES AND ENVIRONMENT:
Our body size depends on the complex interaction between
environmental factors and genetic background. Only 40% variance in body
mass is explained by genetic background in humans 44. Persons with genetic
predisposition are more prone for weight gain and develop obesity related
diseases when they are exposed to a modern lifestyle during their life time.
INFLUENCES OF CHILDHOOD AND PARENTAL OBESITY
The risk of getting obesity in adulthood also depends on being obese
as a child or having at least one obese parent. This risk increases with
increasing age and with degree of childhood obesity.
MONOGENIC CAUSES OF OBESITY
Leptin gene mutation:
In Leptin gene mutated obese individuals, deﬁciency of leptin causes severe
hyperphagia and obesity in both humans and animals, with physiological
leptin replacement ameliorating both the hyperphagia and obesity.
Serum leptin levels increase exponentially with fat mass, which
shows that in obesity there is insensitivity to leptin resulting in body fat
deregulation45
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Leptin receptor mutation:
Mutation in leptin receptor gene resulted in hypogonadotropic
hypogonadism, failure of pubertal development, secondary hypothyroidism,
and delay in growth. These findings confirm the importance of leptin in
endocrine regulation of energy balance and hypothalamic functions in
humans
Certain other mutations leading to obesity are pro-opiomelanocortin
gene mutation(POMC), melanocortin 4 receptor mutations, prohormone
convertase 1 gene mutation and mutation of Neurotrophin receptor TrkB.
POLYGENIC CAUSES OF OBESITY
Obesity may result from gene –environment interactions or due to
gene-gene interactions. The major breakthrough given by genome-wide
association studies was the discovery of fat mass and obesity associated gene
(FTO)46. Many studies have shown that a strong association between single
nucleotide polymorphism in FTO gene and fat mass (BMI) in both adult and
childhood obesity.
ROLE OF EDC
Numerous studies link exposure to EDCs to a variety of
outcomes of potential relevance to obesity, including stimulation of
adipogenesis and changes of insulin secretion, insulin sensitivity, and liver
metabolism47.That the increase of human exposure to EDCs parallels the rise
27
in obesity rates in the United States (raises the possibility of a causal link
between the two).
Modern lifestyle has had a major influence on body energy use vs.
storage. With all kinds of foods becoming readily available at any times
while humans are sedentary, the combination of higher energy intake and
less energy expenditure is at the heart of the obesity problem. Some factors
are shown to be involved in abdominal obesity include age, gender, ethnic,
inherited genes, stress, sex steroid hormones, nutrition, and physical
activity/exercise
Interactions between genes, development, and environment
Environmental factors includes changes of diet composition
and lifestyle, environmental toxins, infections, changes in the
microbiome48along with maternal obesity and diabetes. Vertical
transmission of phenotype could exacerbate (or mitigate) shared genetic
predispositions between mother and o spring while also a ecting the
phenotypes of progeny in the absence of primary genetic predisposition.
Genes that contribute to obesity susceptibility through direct e ects on
energy intake and expenditure may also inﬂuence the response to
developmental/ environmental factors, such as intrauterine and perinatal
exposures to “obesogenic” diets, toxins, and others.
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Role of epigenetic modiﬁcations
Epigenetic modiﬁcation of genes typically involves changes in how
transcriptional complexes access regulatory elements in the genome and can
occur during development and throughout life.
GI factors, bariatric surgery, and the microbiome
Bariatric surgical procedures can produce profound and long-lasting
e ects on body weight. Chief among these procedures are Roux-en-Y
gastric bypass and vertical sleeve gastrectomy, each of which can produce
profound and sustained weight loss that cannot be reliably achieved by other
means  because these procedures alter communication between the GI tract
and energy homeostasis neurocircuits (referred to as the “gut–brain axis”)49.
The gut microbiome and other GI factors
The composition of the gut bacteria in humans has also been linked to
obesity risk50. Alterations in diet can profoundly a ect the composition of
gut bacteria at multiple levels of the GI tract, and obesity itself may also
a ect the composition of gut bacteria.
Social and economic factors
Low-cost foods with high energy density and high reward value, are
readily available in underserved areas, and tend to be preferentially selected
by lower income groups51. Excess consumption of such foods is linked to
rising obesity rates. The concept of a “food desert,” deﬁned as a low-income
area in which the nearest supermarket is atleast 1 mile away, has become a
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focus of public health policies aimed at improving both diet and health.
Studies suggest that BMI tends to be lower in areas where the consumption
of vegetables and fruits is higher 52
Roles of sedentary behavior, lack of exercise, and nonexercise activity
thermogenesis also plays a major role.
Smoking cessation is reliably associated with weight gain53, presumably
owing to withdrawal of the pharmacological e ect of nicotine to suppress
food intake and weight gain.
Fuel partitioning, insulin, and obesity
More recent brain-centric models, in which the brain, by virtue of its
operational control of food intake and energy expenditure, imposes excess
calories on passive adipocytes sometimes referred to as “pull” and “push”
models, respectively54.Embedded within this debate is the extent to which
adipocyte autonomous processes can pull substrate molecules preferentially
into adipocytes, and by “partitioning” calories in this way cause higher
fractional deposition of calories as fat.
COMMON HEALTH CONSEQUENCES OF OVERWEIGHT AND
OBESITY
Increased BMI is one of the major risk factor for noncommunicable
diseases,
 Cardiovascular diseases mainly stroke and heart disease- leading
cause of death in 2012 as per WHO report
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 Diabetes
 Musculoskeletal disorders like osteoarthritis
 Cancer - In 2007, the National Cancer Institute estimated that 4%
of cancers in men and 7% of cancers in women were attributable
to obesity, numbers that can be expected to rise as obesity
increases.
The clearest associations with increased risk were for cancers of
the esophagus, pancreas, colon and rectum, breast, endometrium,
kidney, thyroid, and gallbladder. The mechanisms by which
obesity promotes cancer development are unknown.
The risk for these diseases increases with increasing BMI. Childhood
obesity has a higher chance of obesity in adult, disability in adulthood and
premature death.
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Oxidative   Stress and Endothelial Dysfunction
In non diabetic humans, fat accumulation is correlated with oxidative
stress55. Insulin exerts pro- and anti-atherogenic actions on the vasculature.
The balance between nitric oxide (NO)-dependent vasodilator actions and
endothelin-1- dependent vasoconstrictor actions of insulin is regulated by
phosphatidyl inositol3kinase-dependent (PI3K) - and mitogen-activated
protein kinase (MAPK)-dependent signaling in vascular endothelium,
respectively. During insulin-resistant conditions, pathway-specific
impairment in PI3K-dependent signaling may cause imbalance between
production of NO and secretion of endothelin-1 and lead to endothelial
dysfunction. Insulin resistance produces impairment in PI3kinase dependent
signaling pathway. Hence Endothelial dysfunction causes an imbalance
between nitric oxide production and endothelin 1 secretion56.
Weight of The Heart in Obesity
Hearts of obese individuals have extensive subepicardial fat depots.
Study also reported the presence of fat deposits up to 50% of the heart weight
without any sign of abnormal heart function57.
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VASCULAR SYSTEM AND ATHEROSCLEROSIS
Structure of Vascular Wall
Arteries have a trilaminar structure. The inner “intima” layer consists
of a monolayer of endothelial cells. The middle layer or the “tunica media”,
consists of layers of smooth-muscle cells. The outer layer “the adventitia”,
consists of looser extracellular matrix which may have occasional
fibroblasts, nerve terminals and mast cells. The medium-sized muscular
arteries contain a “prominent tunica media” and atherosclerosis commonly
affects this type of muscular artery57.
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Endothelial Cell
It forms the interface between blood compartment and the tissues. The
ability of endothelial cells to serve as a selectively permeable barrier fails
in:
 Atherosclerosis
 Hypertension
 Renal disease and
 Other situations of "capillary leak"(pulmonary oedema)
The endogenous substances produced by endothelial cells are
 Prostacyclins
 endothelium-derived hyperpolarizing Factor
 nitric oxide (NO) and
 hydrogen peroxide
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Basal and activated endothelial cell states
Under physiologic condition they provide a tonic vasodilatory stimuli
in vivo. Impaired production or excess catabolism of NO impairs this
endothelium-dependent vasodilator function and may contribute to
excessive vasoconstriction in various pathologic situations.
Under pathologic conditions the excessive production of reactive
Oxygen Species (e.g superoxide anion) by endothelial or smooth muscle
cells can promote the local oxidative stress and also inactivates the NO58.
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Endothelial cell Injury
Endothelial cell injury is the cornerstone of the response-to-injury
hypothesis. The two most important causes are hemodynamic
disturbances and hypercholesterolemia.
Hemodynamic Disturbances
Plaques occur at ostia of exiting vessels, branch points, and along the
posterior wall of the abdominal aorta, where there are disturbed flow
patterns. Nonturbulent laminar flow leads to the induction of endothelial
genes whose products (e.g., the antioxidant superoxide dismutase) actually
protect against atherosclerosis and vice versa.
Dyslipoproteinemias include (1) increased LDL cholesterol (2)
decreased HDL cholesterol, and (3) increased levels of the abnormal
lipoprotein (a) which are associated with an increased risk of atherosclerosis.
The dominant lipids in atheromatous plaques are cholesterol and cholesterol
esters.
Hypercholesterolemia cause endothelial cell membrane and
mitochondrial damage, increased local reactive oxygen species production,
and accelerates nitric oxide decay, damping its vasodilator activity59.
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Vascular Wall Response to Injury
Endothelial Junctions are largely impermeable but in
inflammationeven leukocytes can slip between adjacent endothelial cells.
Endothelial cells can respond to various stimuli by a process termed
endothelial activation. Activated endothelial cells express adhesion
molecules(VCAM-1) and produce cytokines and chemokines, growth
factors, vasoactive molecules that result either in vasoconstriction or
vasodilation. Major histocompatibility complex molecules, procoagulant
and anticoagulant factors, biologically active products are responsiblefor
atherosclerosis, and the vascular lesions of hypertension. Vascular smooth
muscle cells(VSMC)are the predominant cellular element of the vascular
media, involved in vascular repair and atherosclerosis60. Also smooth
muscle cells have the capacity to proliferate and synthesize collagen, elastin,
and proteoglycans and elaborate growth factors and cytokines.
Intimal Thickening: A Stereotyped Response to Vascular Injury
Vascular injury—associated with endothelial cell dysfunction or
loss—stimulates smooth muscle cell recruitment and proliferation and
associated matrix synthesis resulting in intimal thickening. The resulting
neointima is typically completely covered by endothelial cells. Thus, intimal
thickening is the response of the vessel wall to any insult. In contrary,
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neointimal smooth muscle cells are motile, undergo cell division, and
acquire new biosynthetic capabilities and its functions are regulated by
cytokines, growth factors derived from platelets, endothelial cells, and
macrophages, as well as thrombin and activated complement factors and this
healing response results in intimal thickening that may impede vascular
flow.
Atherosclerosis, from Greek root words meaning “gruel” and
“hardening,” is involved in the pathogenesis of coronary, cerebral and
peripheral vascular disease. Risk factors have been identified through
prospective analyses (e.g., the Framingham Heart Study) and have roughly
multiplicative effect61.
Diets low in cholesterol and/or high in polyunsaturated fats lower
plasma cholesterol levels.Omega-3 fatty acids (abundant in fish oils) are
beneficial. Statins act by inhibiting hydroxyl methylglutaryl coenzyme A
(HMG CoA) reductase, the rate-limiting enzyme in hepatic cholesterol
biosynthesis, have been used widely to lower serum cholesterol levels.
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Premenopausal women are relatively protected against
atherosclerosis. After menopause the incidence of atherosclerosis related
diseases increases in women. Assessment of systemic inflammation is done
by C-reactive protein (CRP)62. Lipoprotein(a) levels are also associated with
disease risk.
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Stereotypical response to vascular injury
Pathogenesis of Atherosclerosis
“Response to injury” hypothesis model
Atherosclerosis is a chronic inflammatory and healing response of the
arterial wall to endothelial injury.
Lesion progression occurs through interaction of modified lipoproteins
LDL, monocyte-derived macrophages, and T lymphocytes with endothelial
cells and smooth muscle cells of the arterial wall.
Endothelial injury and dysfunction, causing increased vascular
permeability, leukocyte adhesion, and thrombosis
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Accumulation of lipoproteins (mainly LDL and its oxidized forms) in the
vessel wall
Monocyte adhesion to the endothelium, followed by migration into the
intima and transformation into macrophages and foam cells
Platelet adhesion
Factor released from activated platelets, macrophages, and vascular wall
cells, inducing smooth muscle cell recruitment, either from the media or
from circulating precursors
Smooth muscle cell proliferation, extracellular matrix production, and
recruitment of T cells.
Lipid accumulation both extracellularly and within cells (macrophages and
smooth muscle cell)
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Inflammation
Chronic inflammation is triggered by the accumulation of cholesterol
crystals and free fatty acids in macrophages and other cells. The resulting
inflammasome activation leads to the production of the pro-inflammatory
cytokine IL-1 and macrophage and T cell activation63.
Intimal smooth muscle cell proliferation and extracellular matrix
deposition convert a fatty streak into a mature  atheroma and contribute to
the progressive growth of atherosclerotic lesions. Intimal smooth muscle
cells have a proliferative and synthetic phenotype distinct from the
underlying medial smooth muscle cells. Platelet-derived growth factor
fibroblast growth factor, and transforming growth factor-α estimulate
smooth muscle cells to synthesize extracellular matrix (collagen), which
stabilizes atherosclerotic plaques. The key processes in
atherosclerosis are intimal thickening and lipid accumulation,
which together form plaques and vessels involved are the abdominal
aorta, the coronary arteries, the popliteal arteries, the internal carotid
arteries, and circle of Willis.
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Atherosclerotic plaques have three principal components: (1) smooth
muscle cells, macrophages, and T cells; (2) extracellular matrix, including
collagen, elastic fibers, and proteoglycans; and (3) intracellular and
extracellular lipidand a fibrous cap, with a necrotic core, containing lipid
(primarily cholesterol and cholesterol esters), foam cells (lipid
laden macrophages and smooth muscle cells),fibrin, thrombus,
and plasma proteins; The periphery of the lesions show
neovascularization64.Atherosclerotic plaques undergo ,rupture or
ulceration, Hemorrhage  or Atheroembolism  and Aneurysm formation-
Atherosclerosis-induced pressure or ischemic atrophy of the
underlying media, with loss of elastic tissue, causes weakness
and potential rupture.
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Large elastic arteries (e.g., aorta, carotid, and iliac arteries) and large
and medium-sized muscular arteries (e.g., coronary and popliteal arteries)
are the major targets of atherosclerosis.
At early stages of atherosclerotic stenosis, outward remodeling of the
vessel media tends to preserve the size of the lumen. Critical stenosis
produce tissue ischemia, when there is 70% decrease in luminal cross-
sectional area.
The major structural component of the fibrous cap is the collagen and
accounts for its mechanical strength and stability. Collagen in
atherosclerotic plaque is produced primarily by smooth muscle cells so that
loss of these cells results in a less sturdy cap65. Moreover, collagen turnover
is controlled by metalloproteinases (MMPs), enzymes elaborated largely by
macrophages and smooth muscle cells within the atheromatous plaque;
conversely, tissue inhibitors of metalloproteinases (TIMPs) produced by
endothelial cells, smooth muscle cells, and macrophages modulate MMP
activity. Conversely, statins have a beneficial therapeutic effect by
stabilizing plaques through a reduction in plaque inflammation. Thrombin
is a potent activator of smooth muscle cells and can thereby contribute to the
growth of atherosclerotic lesions.
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HYPERTENSION AND VASCULAR WALL
BLOOD PRESSURE
Physician William Harvey (1578–1657), described the circulation of
blood in his book "De motucordis". The English clergyman Stephen
Hales made the first published measurement of blood pressure in 173366. In
the year 1828, mercury sphygmomanometer was discovered by Bernoulli.
The first report of elevated blood pressure in a person without
evidence of kidney disease was made by Frederick Akbar Mahomed in 1874
using a sphygmograph. Cuff-based sphygmomanometer by Scipione
Riva-Rocci in1896 allowed blood pressure to be measured in the
clinic. In 1905, NikolaKorotkoff improved the technique by describing
the Korotkoff sounds.
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BP   =     CARDIAC OUTPUT X TOTAL PERIPHERAL RESISTANCE
• Cardiac output is a function of stroke volume and heart rate.
• Peripheral resistance is regulated predominantly at the level of the
arterioles by neural and hormonal inputs.
Blood pressure regulation
Systolic pressure: It is defined as the maximum pressure which is
reached during the cardiac cycle. It indicates the force
of contraction of heart.
Diastolic pressure: It is defined as the minimum pressure attained during
the cardiac cycle. It depends on the total peripheral
resistance.
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Hypertension causes arterial wall thickening and loss of elasticity –
Arterioscleosis means “hardening of the arteries”.
Sustained diastolic pressures above 89 mm Hg or sustained systolic
pressure above 139 mm Hg are associated with increased risk of
atherosclerotic disease, and are thus considered clinically
significant67.Hypertension causes cardiac hypertrophy and heart failure,
multi-infarct dementia, aortic dissection, and renal failure. Hypertension
remains asymptomatic until late in its course.
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As per Framingham heart study, rise in systolic blood pressure by
20mm Hg and the risk for cardiac failure increases by 56%80. This was
proposed by Adler et al80
Pathogenesis of Hypertension
Hypertension is a disorder with multiple genetic and environmental
contributions.
 Vast majority causes (90% to 95%) of hypertension is
idiopathic.
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 In renovascular hypertension, renal artery stenosis induces
renin secretion and  increases vascular tone  and blood volume
via the angiotensin-aldosterone pathway.
 Single-gene disorders
 Gene defects affecting enzymes involved in aldosterone
metabolism
 Mutations affecting proteins that influence sodium
reabsorption e.g.,Liddle syndrome, epithelial Na+ channel
proteins
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Mechanisms of Essential Hypertension
 Genetic factors influence blood pressure regulation, by altering net
sodium reabsorption in the kidney. Cumulative effects of
polymorphisms in genes  affect blood pressure;
 Reduced renal sodium excretion in the presence of normal arterial
pressure may be a key initiating event in essential hypertension, a final
common pathway for the pathogenesis of hypertension. “Resetting of
pressure natriuresis” plays a role68.
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 Renin is an enzyme produced by renal juxta glomerular cells, myo
epithelial cells that surround the glomerular afferent arterioles
released to increase sodium resorption by the proximal tubules as
needed and also cleaves plasma angiotensinogen to angiotensin I.
 Vaso constrictive influences or stimuli that cause structural changes
in the vessel wall, can lead to an increase in peripheral resistance and
may also play a role in essential hypertension.
 Environmental factors like obesity, smoking, physical inactivity, and
heavy salt consumption, stress are all noted in hypertension.
Hypertension not only accelerates atherogenesis but also causes
degenerative changes in the walls of large and medium arteries69.
Hypertension induced structural changes in vasculature:
Hypertension is a disorder of heart and blood vessels. They adapt their
structure in response to altered load. This occurs physiologically and
pathologically in hypertension. Increased pressure exerts an increased load
on a thin walled chamber or tube by increasing wall tension according to
Laplace’s law. A rise in tension results in increased wall tensile stress.
Normalisation of wall tensile stress can be achieved either by an increase in
wall thickness or by a reduction in chamber/ lumen diameter, or both.
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The elevated pressure causes an increase in wall tension that is largely
experienced by vascular myocytes and the extracellular matrix of the blood
vessel70. The diameter of large elastic arteries such as the aorta or carotid is
increased in hypertension. There is also an increase in wall thickness (or at
least intima–media thickness (IMT) as measured by ultrasound)19 The rise
in pressure distends the vessel, while the increased media thickness
normalises media stress. Blood vessels do not obey Hooke’s law and are
non-linearly elastic—i.e., they become stiffer when distended.Pro-
hypertensive factors contribute to endothelial barrier dysfunction72. For
example, angiotensin-II (Ang-II) disrupts the blood brain barrier in
spontaneously hypertensive rats (SHR) and aldosterone can diminish
endothelial nitric oxide synthase activity via rearrangement of the actin
cytoskeleton. RhoA the master regulator of actin cytoskeleton formation, an
improvement in endothelial barrier function could be another mechanism.
Hence RhoA/ROCK inhibition (e.g. fasudil) acts as an anti-hypertensive
therapy. Similar to vasoactive molecules, novel mediators of endothelial
permeability and actin cytoskeleton dynamics are emerging.
Overall, the metabolism of endothelial cells becomes dysfunctional
promoting a pro-contractile, pro-inflammatory, and pro-oxidative milieu in
hypertension.
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Role of Tunica Media -Vascular Smooth Muscle Cells
VSMCs are embedded in a network of elastin-rich extracellular matrix and
the basement membrane, which surrounds each VSMCs and separates the
VSMCs-containing medial cell layer from the endothelium (73). VSMCs
structural changes in hypertension are termed VASCULAR
REMODELING. Vascular remodeling is classified as hypertrophic,
eutrophic or hypotrophic. Remodeling can be inward (reduced luminal
diameter) or outward (increased luminal diameter) 74
The most common type in hypertension is inward remodeling,
causing a reduction of the luminal diameter under passive conditions.
Outward remodeling is generally seen during antihypertensive treatment,
and  in conditions of increased flow
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During hypertension, VSMCs undergo hyperplasia and hypertrophy
which is responsible for the vascular inward remodeling and subsequent
development of increased total peripheral resistance
Fibroblasts are the principal cells for vascular remodeling in response
to injury75. However, during hypertension, fibroblasts also undergo a
morphological change, with proliferation and migration into the tunica
media . This response to injury also leads to the production of chemokines,
cytokines, adhesion molecules, reactive oxygen species and matrix
metalloproteinases, along with proliferation of the vasa vasorum, resulting
in irreversible functional and structural remodeling of the vessel wall. The
peri vascular adipose tissue (PVAT) anticontractile action is lost in
hypertension.
In dysfunctional PVAT (e.g., hypertension), immune cell infiltrates in
the perivascular adipose tissue also contributes to the low-grade
inflammation seen in multiple cardiovascular diseases.
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Sequence of cellular interactions in atherosclerosis
.
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STATISTICAL ANALYSIS
Statistical analysis was performed using the Statistical Package for the
Social Sciences (SPSS), Version 22. Descriptive quantitative data were
presented as frequencies or means ± standard deviation (SD). Correlation of
two continuable variables were done using Pearson Correlation test. One-
way ANOVA was used to compare the groups. Cross tabulation were used
to check the association between categorical variables. P value of <0.05 was
considered statistically significant. .
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RESULT
A total of 100 subjects between 31–60 years were included in the
study (mean age: 46.23±8.56 years).There were 49 males and 51 females in
the study group.
The demographic characteristics of the subjects by age group are
shown in Table 2 and Graph 2
Table 2
Age group distribution
AGE Group (in years) Frequency Percent
31-40 34 34.0%
41- 50 25 25.0%
51-60 41 41.0%
Total 100 100.0%
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Graph -2
Age group distribution
All subjects were grouped into three groups age wise, 31 - 40, 41 - 50
and 51 – 60 years with a frequency of 34, 25 and 41 respectively. Among
the subjects, age group 51-60 years has the highest frequency (shown in
figure 1 and graph 1)
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By gender wise classification females are higher in number (59%), which
is shown in table 3 and graph 3
Table -3
GENDER DISTRIBUTION
SEX Frequency Percent
Male 41 41.0%
Female 59 59.0%
Total 100 100.0%
Graph -3
GENDER DISTRIBUTION
Male
41%
Female
59%
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The BMI of participants is classified into four categories based on
Asian Indian criteria. Among them, over weight category has the
highestfrequency (41%), Obesity category (32%) and normal BMI (26%)
respectively. Mean BMI of these categories is 26.53±4.03.
TABLE 4
BMI FREQUENCY DISTRIBUTION
BMI Frequency Percent
Normal 26 26.0%
Over weight 41 41.0%
Obesity 32 32.0%
Extreme Obesity 1 1.0%
Total 100 100.0%
GRAPH 4
BMI DISTRIBUTION
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The frequency of subjects by Systolic BP classification is tabulated
in table no. 5 and is depicted in graph 5
Among these groups, pre hypertensive subjects have the highest
frequency (77%), followed by stage I hypertensive (18%) and Normal
subjects (5%)
TABLE 5
DISTRIBUTION BY SYSTOLIC BLOOD PRESSURE
SBP Frequency Percentage
Normal 5 5%
Pre hypertension 77 77%
Stage 1 Hypertension 18 18%
Total 100 100%
GRAPH 5
DISTRIBUTION BY SYSTOLIC BLOOD PRESSURE
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HT classification by DBP is done and tabulated in table no.6 and also
shown graphically in graph 6
Stage I hypertensive subjects are higher in number (65%), followed by
prehypertensive subjects (29%) and Normal subjects (5%)
TABLE 6
FREQUENCY DISTRIBUTION BY DIASTOLIC BLOOD
PRESSURE
DBP Frequency Percentage
Normal 5 5%
Pre Hypertension 29 29%
Stage 1
Hypertension 65 65%
Stage 2
Hypertension 1 1%
GRAPH 6
FREQUENCY DISTRIBUTION BY SYSTOLIC BLOOD
PRESSURE
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Of the 100 subjects, 100 (100 %) completed the study and carotid artery
scanning done. The CIMT measurement was performed in all the subjects.
The percentage of frequency distribution is calculated and represented in
table no.7 and pie graph. In that, normal and abnormal values are 80% and
20% respectively.
Table No 7
CIMT distribution
CIMT Frequency Percent
Normal (<.9 mm) 80 80.0%
Abnormal (>.9 mm) 20 20.0%
Total 100 100.0%
Graph 7
CIMT DISTRIBUTION
Normal
80%
Abnormal
20%
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Mean CIMT of the right side is0.77±.15   and left side is 0.76 ± .18 and is
tabulated in Table 8
TABLE 8
Mean CIMT Side-Side
Mean CIMT SD P value
Rt side 0.77 0.15 <0.21
Lt side 0.76 0.18
There is no significant difference between the two sides, p value is < 0.21.
Mean CIMT of the males and females with normal BMI category is
0.81 and 0.58 respectively. Over weight males and females have mean
CIMT 0.85 and 0.71 respectively. Obese males and females have mean
CIMT 0.93 and 0.76 respectively.
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Table 9
BMI vs Gender vs Mean CIMT
BMI GenderMale Female
Normal 0.81 0.58
Over weight 0.85 0.71
Obesity 0.93 0.76
Extreme Obesity - 0.94
Graph 8
BMI vs Gender vs Mean CIMT
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Mean CIMT of the normal BMI category  by age group wise are 0.57,0.67
and 0.81 respectively. Mean CIMT of the Overweight BMI category  by age
groupwise are 0.64,0.76 and 0.85 respectively. Mean CIMT of the Obesity
category  by age groupwise are 0.65,0.78 and 0.96 respectively.
Table 10
BMI vs Age vs CIMT
BMI 31-40 41- 50 51-60
Normal 0.57 0.69 0.81
Over weight 0.64 0.76 0.85
Obesity 0.65 0.78 0.96
Extreme Obesity 0.94
Graph 09
BMI vs Age vs CIMT
0.57 0.64 0.65
0.94
0.69 0.76
0.780.81 0.85
0.96
0
0.2
0.4
0.6
0.8
1
1.2
Normal Over weight Obesity Extreme Obesity
31-40 41- 50 51-60
68
We analysed the relationship statistically between the age, gender,
BMI, systolic blood pressure and diastolic blood pressure with carotid artery
intima media thickness (CIMT).
Pearson correlation analysis shows Age correlation (r value–0.806
and P value <0.001),Gender correlation (r value 0.12 and  p value <0.001),
BMI Correlation (r value 0.418 and P value  <0.001), systolic blood pressure
Correlation (r value – 0.419 and P value < 0.001) and diastolic blood
pressure Correlation (r value – 0.473  and P value <0.001).All the parameters
show significant  positive correlation and p values.
Age has more positive correlation with CIMT.As age advances CIMT
is also increased. By genderwise CIMT is increased more in males when
compared to females. Overweight and obesity category reflects increased
BMI  individuals with increased CIMT proportionately.
The Systolic and diastolic blood pressure parameters are positively
correlated and increased proportionally with CIMT.
The following datas are shown in the graphs and Tables
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GRAPH 10
Correlations Age vs CIMT
Correlation value – 0.806 (Good correlation)
P value - <0.0001
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Mean CIMT of all the males is 0.88±0.13 and Mean CIMT of all the females
is 0.69±0.12 and has significant p values and are shown in Table and graph
TABLE -11
Gender Vs CIMT
Gender N
Mean
CIMT
Std.
Deviation P value
Male 41 0.88 0.13 <0.0001Female 59 0.69 0.12
GRAPH -11
Gender Vs CIMT
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Mean CIMT of the normal BMI subjects is 0.64±0.12, Over weight subjects
has 0.78±0.11 and  overweight people has  0.85±0.16.All categories have
significant p values<. .001
TABLE -12
BMI vs CIMT
BMI N Mean CIMT Std.Deviation P value
Normal 26 0.64 0.12
<0.0001
Over weight 41 0.78 0.11
Obesity 32 0.85 0.16
Extreme
Obesity 1 0.94 -
GRAPH -12(a)
BMI vs CIMT
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Graph 12 (b)
CORRELATION BMI vs CIMT
BMI Correlation r value = 0.418 and P value  <0.001
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Mean CIMT of the subjects having normal SBP is 0.52±0.02, Pre
hypertensive subjects have 0.78±0.11 and  Stage 1 hypertensives have
0.85±0.16.All categories have significant p values <0.001 and has good
correlation with CIMT.
Table 13
SBP Vs MEAN CIMT
SBP N MeanCIMT Std. Deviation P value
Normal 5 0.52 0.02
<0.0001Pre-Hypertension 77 0.76 0.15
Stage 1
Hypertension 18 0.85 0.12
Graph -13
Correlations SBP vs CIMT
Correlation value – 0.419 (Moderate correlation)
P value = 0.001
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Mean CIMT of  the subjects having normal DBP is 0.52±0.02, Pre
hypertensive subjects have 0.78±0.11 and  Stage 1 hypertensives have
0.85±0.16.All categories have significant p values <0.001 and have good
correlation with mean CIMT
Table -14
DBP vs IMT
DBP N Mean CIMT Std. Deviation Pvalue
Normal 5 0.60 0.05
0.009Pre-Hypertension 29 0.72 0.11Stage 1 65 0.80 0.17
Stage 2 1 0.68 -
Graph -14
Correlations DBP vs CIMT
Correlation value – 0.473 (Moderate correlation)
P value <0.0001
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DISCUSSION
In our study, we found that the mean CIMT of normal healthy persons
(including all age group) was 0.77+.16mm.
Levenson J et al, Wendelhag I et al, Deepa R et al, Siva Kumar V et al,
Riley WA et al showed the  near similar values (61-65).
In our study there was progressive increase in CIMT from 31 to 58 years in
all the subjects.
Our study also showed that CIMT is positively correlated with age (P
value<0.001) and was higher in the age group of 50-58 years, than lower age
groups.
ChatautSP et al,Zavodna E et al, Adeyinka AO et al, Ribeiro AB et al,
Savolainen M et al,Torng PL et al, Coresh J et al, Li S et al, Grobbee
DE et al.,studies consistently showed increased CIMT with age(66-75)
There was significant correlation between CIMT and sex (P value=0.001)
and also higher CIMT was seen in males than  females in this study.
Torng PL et al,Coresh J et al, Li S et al,Grobbee DE et al.studies showed
the similar correlation with gender (72,73,74,75).
In the current study, a positive correlation was observed between CIMT and
BMI (r value = 0.32 ).The change was greater in higher BMI groups (over
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weight and obese individuals) than in  normal  individuals, suggesting a
more rapid change in IMT for BMI values > 23.5 kg/m2
Sorlie P et al , Urbina EM et al,Ducimitere P et al and Sasaki et al have
reported similar positive association between CIMT and BMI(76-79).
In our study mean CIMT of hypertensive patients by systolic and diastolic
wise criteria are 0.84+.14 and 0.79+.10 mm respectively.
In our study, CIMT correlated positively with SBP and DBP of all the
subjects Pearson correlation for SBP (r value=0.41) and DBP (r value=0.47).
This was consistent with Zavodna E, et al. Ribeiro AB, et al, de Faire U,et
al studies despite differences in the methodology employed in measurement
of blood pressure. While blood pressure was taken at presentation in this
study; other studies used 24h SBP and DBP measurement method.(80,81,82)
In his study, Sasaki et al, showed that vascular remodeling is the cause of
carotid arterial changes. In the early atherosclerosis stages, a compensatory
mechanism prevents narrowing coincident with an increase in IMT.
Although it is a compensatory mechanism, hemodynamic changes still occur
in the walls of the arteries resulting in arterial disease.[719]
In hypertensives, higher CIMT values  is observed with age which could
probably be due to the combined effect of increased blood pressure levels
and aging process on the intima media. Also the impact of blood pressure
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levels on the intima media has been considered as an accelerated form of
aging and hypertensive patients develop aging process in their arterial walls
earlier in life than normotensives.
In hypertensives, elevated blood pressure level can cause injury to the
endothelium of blood vessels with subsequent thickening of intima media
complex via medial hypertrophy,[81,83] a process specifically related to the
disease.
Savolainen M et al, de Faire U et al, showed similar results.(80,82)
This thickening of the arterial wall is probably an adaptive mechanism to
compensate for the persistent increase in blood pressure levels[80] and the
thickening of the vessel wall have been demonstrated in vivo and in vitro.[84]
Therefore, increase in blood pressure has a significant effect on the IMT.
Ribeiro AB et al, Simon A et all showed similar results(69,71),
Davis et al. reported cross-sectional associations between c-IMT and
cardiovascular risk factors 9,
In the current study, the correlation between carotid atherosclerosis and
HTN was significant.
In our study, the method used in arriving at CIMT value involved taking
three measurements 1cm proximal to right and left carotid bulb and the mean
value of the three measurements were recorded for each side; this was
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different from the method employed in some other studies.[80,85] This method
is simple, reliable, and reproducible. There is minimal inter- and intra
observer error[86].
There was no significant side-side difference noted in the mean CIMT for
both left and right sides. Ibinaiye et al, limbu et al, noted similar
observations(84,85).
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CONCLUSION
 OBESITY is an emerging major chronic health problem and a
neglected problem globally, with India being one among them. So this
study was done to bring out the association between BMI and blood
pressure with carotid artery intima media thickness, a surrogate
marker of atherosclerosis in the systemic vessels.
 This cross sectional study was done in Tirunelveli Medical College
hospital. Sample size was 100. BMI and blood pressure were
measured and CIMT was measured using carotid Doppler
ultrasonography.
From our study we conclude, that
1) BMI has positive correlation with CIMT values.
2) Blood pressure also has significant positive correlation with CIMT
values.
3) Agewise there is a progressive increase in CIMT values.
4) Genderwise, males have a higher CIMT values than female
counterparts.
Hence we recommend Carotid Doppler sonography, as a screening
tool to be included in the routine Master health checkup programme
to monitor the ongoing atherosclerotic changes in vessel wall.
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LIMITATIONS OF THE STUDY
This study has its own limitations
 The number of patients in this study is small. Hence generalization of
results of the study have to be made with caution.
 The study population involved patients seeking medical care in our
hospital which is a tertiary care center and hence they may not
represent the general population
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FUTURE SCOPE
 In future, this study can be extended among large number of people
including both males and females
 Serum leptin, hs CRP and adiposity inflammatory markers can be
included to identify the vulnerable population.
 Early detection and timely intervention in the vulnerable population
will go a long way in preventing sudden cardiac and cerebro vascular
accidents.
 Primary health care providers should be made aware of this potential
future screening tool.
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PROFORMA
Name     :
Age/Sex:
Residential Address:
H/o:
Diabetes mellitus Y N
Hypertension Y N
Thyroid & other endocrine disease Y N
Ischemic heart disease Y N
Stroke Y N
Bronchial Asthma Y N
Vasculitis disorders Y N
Chronic Steroids usage Y N
Statin therapy Y N
CLINICAL EXAMINATION
Height: cms
Weight: kgs
BMI:
PR:
BP      : mmhg
Respiratory system:
Cardiovascular system:
CNS:
Carotid artery measurement
Carotid Bulb Proximal bulb Distal bulb
Right Side
Left Side
BODY MASS AND OBESITY
 DEFINITION OF OBESITY
 PREVALENCE OF OBESITY
o GLOBAL SCENARIO
o INDIAN SCENARIO
 OBESITY AND ANTHROPOMETRY
 BODY MASS INDEX(BMI)
 PATTERNS OF OBESITY
 ENERGY BALANCE
 DIETARY LIPIDS / LIPO PROTEINS
 STORAGE OF LIPIDS AS TRIGLYCERIDES
 ROLE OF HORMONES
 FAT AS AN ORGAN
 PATHOGENESIS OF OBESITY
o GENES AND ENVIRONMENT
o INFLUENCES OF CHILDHOOD AND PARENTAL OBESITY
o MONOGENIC CAUSES OF OBESITY
o POLYGENIC CAUSES OF OBESITY
o ROLE OF EDC
o INTERACTIONS BETWEEN GENES, DEVELOPMENT, AND
ENVIRONMENT
o ROLE OF EPIGENETIC MODIFICATIONS
o GI FACTORS, BARIATRIC SURGERY, AND THE
MICROBIOME
o THE GUT MICROBIOME AND OTHER GI FACTORS
o SOCIAL AND ECONOMIC FACTORS
o ROLES OF SEDENTARY BEHAVIOR, LACK OF EXERCISE,
AND NONEXERCISE ACTIVITY THERMOGENESIS
o FUEL PARTITIONING, INSULIN, AND OBESITY
 COMMON HEALTH CONSEQUENCES OF OVERWEIGHT AND
OBESITY
 OXIDATIVE   STRESS AND ENDOTHELIAL DYSFUNCTION
 WEIGHT OF THE HEART IN OBESITY
VASCULAR SYSTEM AND ATHEROSCLEROSIS
 STRUCTURE OF VASCULAR WALL
 ENDOTHELIAL CELL
 ENDOTHELIAL CELL INJURY
 HEMODYNAMIC DISTURBANCES
 HYPERCHOLESTEROLEMIA
 VASCULAR WALL RESPONSE TO INJURY
o INTIMAL THICKENING: A STEREOTYPED RESPONSE TO
VASCULAR INJURY
o RISK FACTOR FOR ATHEROSCLEROSIS
o PATHOGENESIS OF ATHEROSCLEROSIS
o RESPONSE TO INJURY HYPOTHESIS MODEL
HYPERTENSION AND VASCULAR WALL
 BLOOD PRESSURE HISTORY
 PATHOGENESIS OF HYPERTENSION
 MECHANISMS OF ESSENTIAL HYPERTENSION
 HYPERTENSION INDUCED STRUCTURAL CHANGES IN
VASCULATURE
 ROLE OF   TUNICA MEDIA -VASCULAR SMOOTH MUSCLE
CELLS
Sl.No AGE SEX Height(cm)
Weight
(Kg) BMI
SBP
mmHg
DBP
mmHg
CIMT
RT
CIMT
LT
Mean
IMT
1 54 1 166 51 18.5 138 86 0.794 0.77 0.782
2 50 2 162 48 19.7 140 90 0.722 0.71 0.716
3 39 2 156 57 20.2 130 90 0.53 0.53 0.53
4 31 2 142 56 20.5 120 70 0.58 0.5 0.54
5 32 2 145 59 20.9 110 90 0.64 0.4 0.52
6 37 2 153 57 20.9 114 80 0.48 0.6 0.54
7 58 1 169 55 21.2 140 86 0.868 0.87 0.869
8 32 2 147 50 21.3 120 90 0.51 0.49 0.5
9 37 2 153 61 21.3 124 80 0.578 0.6 0.589
10 46 2 159 57 21.5 132 90 0.68 0.66 0.67
11 52 1 164 57 21.5 140 84 0.66 0.78 0.72
12 35 2 150 59 21.7 110 80 0.54 0.5 0.52
13 38 2 155 61 22 140 90 0.6 0.58 0.59
14 38 2 154 55 22.03 130 90 0.594 0.58 0.587
15 54 1 166 58 22.1 140 90 0.82 0.8 0.81
16 33 2 148 60 22.3 130 90 0.682 0.5 0.591
17 34 2 149 53 22.3 150 90 0.68 0.6 0.64
18 37 2 154 64 22.4 130 80 0.68 0.56 0.62
19 40 2 156 59 22.4 130 80 0.702 0.67 0.686
20 54 1 165 56 22.4 130 94 0.86 0.86 0.86
21 55 1 168 56 22.4 148 90 0.998 0.7 0.849
22 35 2 152 63 22.58 140 90 0.62 0.5 0.56
23 39 2 156 61 22.6 140 90 0.52 0.5 0.51
24 31 2 142 60 22.8 130 90 0.552 0.56 0.556
25 39 2 156 66 22.83 140 80 0.74 0.7 0.72
26 32 2 148 48 22.87 140 80 0.442 0.6 0.521
27 39 2 156 54 23.37 138 80 0.69 0.67 0.68
28 32 2 147 62 23.66 132 90 0.74 0.5 0.62
29 47 2 159 61 23.8 130 84 0.65 0.63 0.64
30 36 2 153 48 23.88 130 70 0.56 0.6 0.58
31 58 1 169 61 24.5 136 90 0.94 0.9 0.92
32 55 1 168 59 24.6 138 88 0.862 0.84 0.851
33 39 2 156 60 24.69 140 70 0.67 0.67 0.67
34 40 2 156 50 24.87 140 80 0.67 0.67 0.67
35 33 2 148 59 24.89 138 80 0.68 0.5 0.59
36 44 2 158 72 24.9 130 88 0.82 0.76 0.79
37 51 1 163 63 24.9 140 94 0.76 0.8 0.78
38 52 1 164 63 24.9 140 84 0.91 0.87 0.89
39 54 1 165 65 25.1 134 90 0.85 0.83 0.84
40 55 1 167 61 25.1 132 94 0.912 0.88 0.896
41 48 2 160 72 25.5 130 94 0.818 0.76 0.789
42 54 1 165 71 25.5 130 84 0.81 0.83 0.82
43 55 1 167 71 25.5 134 88 0.788 0.78 0.784
Sl.No AGE SEX Height(cm)
Weight
(Kg) BMI
SBP
mmHg
DBP
mmHg
CIMT
RT
CIMT
LT
Mean
IMT
44 47 2 159 56 25.6 134 84 0.72 0.7 0.71
45 54 1 166 56 25.6 138 92 0.79 0.77 0.78
46 40 2 156 70 25.7 134 90 0.7 0.68 0.69
47 38 2 155 63 25.92 134 70 0.62 0.6 0.61
48 48 2 161 72 26.1 136 90 0.804 0.78 0.792
49 50 2 162 59 26.2 130 90 0.92 0.8 0.86
50 50 2 162 66 26.4 136 92 0.758 0.69 0.724
51 52 1 163 57 26.4 138 90 0.69 0.91 0.8
52 48 2 161 70 26.7 138 92 0.786 0.79 0.788
53 53 1 164 72 26.8 130 84 0.8 0.76 0.78
54 48 2 161 74 26.9 140 94 0.848 0.8 0.824
55 53 1 164 76 26.9 138 94 0.816 0.78 0.798
56 40 2 157 66 27 140 80 0.706 0.69 0.698
57 47 2 160 78 27 136 90 0.83 0.79 0.81
58 54 1 165 73 27.1 134 84 0.76 0.76 0.76
59 58 1 170 73 27.1 140 94 1.28 1.2 1.24
60 51 1 163 68 27.2 146 94 0.66 0.92 0.79
61 57 1 169 74 27.2 140 90 0.95 0.89 0.92
62 55 1 168 69 27.3 140 92 0.83 0.85 0.84
63 42 2 158 74 27.5 138 96 0.872 0.7 0.786
64 50 2 162 69 27.6 136 88 0.73 0.69 0.71
65 54 1 165 78 27.6 146 96 0.78 0.8 0.79
66 55 1 168 78 27.6 142 92 0.582 1.2 0.891
67 43 2 158 62 27.9 132 86 0.776 0.75 0.763
68 52 1 164 79 28 140 90 0.798 0.77 0.784
69 53 1 165 69 28.4 140 92 0.91 0.87 0.89
70 58 1 170 70 28.4 138 94 0.72 1.2 0.96
71 49 2 162 74 28.5 134 86 0.68 0.7 0.69
72 43 2 158 78 28.7 136 92 0.798 0.78 0.789
73 35 2 152 67 29 140 70 0.624 0.6 0.612
74 56 1 168 76 29 140 90 0.99 0.79 0.89
75 56 1 169 76 29 146 94 0.934 0.8 0.867
76 56 1 169 65 29.3 140 94 1.26 1.3 1.28
77 52 1 164 64 29.6 138 92 0.82 0.82 0.82
78 54 1 167 74 29.6 142 88 0.99 0.89 0.94
79 55 1 168 72 29.6 140 94 0.93 0.99 0.96
80 48 2 162 85 29.8 142 94 0.816 0.78 0.798
81 58 1 170 85 29.8 146 94 0.68 1.2 0.94
82 56 1 168 70 29.9 138 94 0.94 0.98 0.96
83 39 2 156 89 30.8 140 90 0.72 0.7 0.71
84 50 2 162 74 30.8 142 84 0.85 0.87 0.86
85 58 1 170 89 30.8 136 96 1.22 1.3 1.26
86 45 2 158 82 30.9 142 92 0.726 0.7 0.713
Sl.No AGE SEX Height(cm)
Weight
(Kg) BMI
SBP
mmHg
DBP
mmHg
CIMT
RT
CIMT
LT
Mean
IMT
87 49 2 162 73 30.9 146 94 0.88 0.7 0.79
88 53 1 165 81 30.9 142 94 0.9 0.87 0.885
89 37 2 154 66 31.42 140 94 0.702 0.68 0.691
90 57 1 169 78 32 144 92 0.902 0.89 0.896
91 48 2 161 71 32.4 140 92 0.69 0.67 0.68
92 51 2 163 82 32.4 142 94 1.04 1.2 1.12
93 42 2 158 78 32.5 138 90 0.806 0.79 0.798
94 41 2 158 80 32.9 140 92 0.82 0.8 0.81
95 38 2 155 76 33.7 140 80 0.688 0.67 0.679
96 45 2 159 82 34.6 144 94 0.914 0.88 0.897
97 31 1 145 75 34.71 140 96 0.62 0.6 0.61
98 55 1 168 95 34.9 146 92 0.98 0.9 0.94
99 33 2 149 90 35.85 150 90 0.748 0.5 0.624
100 32 2 148 93 38.27 140 100 0.71 0.65 0.68
CVD-CARDIO VASCULAR DISEASE
BMI-BODY MASS INDEX
AT-ADIPOSE TISSUE
IMT-INTIMA MEDIA THICKNESS
CIMT- CAROTID ARTERY INTIMA MEDIA THICKNESS
CCA-COMMON CAROTID ARTERY
ICA-INTERNAL CAROTID ARTERY
CHD-CORONARY HEART DISEASE
TEE-TOTAL ENERGY EXPENDITURE
REE-RESTING ENERGY EXPENDITURE
TEF-THERMIC EFFECT OF FOOD
VLDL-VERY LOW DENSITY LIPOPROTEIN
LDL- LOW DENSITY LIPOPROTEIN
NPY-NEURO PEPTIDE Y
AgRP-AGOUTI RELATED PEPTIDE
MCH-MELANOCYTE CONCENTRATING HORMONE
MSH- MELANOCYTE STIMULATING HORMONE
PYY-PEPTIDE TYROSINE (3-36)
IAAT-INTRA ABDOMINAL ADIPOSE TISSUE
POMC-PRO OPIO MELANO CORTIN
FTO-FAT MASS AND OBESITY ASSOCIATED
EDC-ENDOCRINE DISRUPTING CHEMICAL
GI-GASTRO INTESTINAL
NO-NITRIC OXIDE
PI3K-PHOSPATIDYL  INOSITOL TRI PHOSPHATE
MAPK-MITOGEN ACTIVATED PROTEIN KINASE
VCAM-VASCULAR CELL ADHESION MOLECULE
CRP-C-REACTIVE PROTEIN
VEGF-VASCULAR ENDOTHELIAL GROWTH FACTOR
IL-1-INTER LEUKIN-1
MMP-MATRIX METALLO PROTEINASE
BP-BLOOD PRESSURE
VSMC-VASCULAR SMOOTH MUSCLE
PVAT-PERI VASCULAR ADIPOSE TISSUE
JNC-JOINT NATIONAL COMMITEE
WHO-WORLD HEALTH ORGANISATION
